Natco Pharma stock zooms 4% after agrochemicals business demerger plan; shareholders set for share swapNatco Pharma stock zooms 4% after agrochemicals business demerger plan; shareholders set for share swap

Introduction

Leading pharmaceutical company approves demerger of its Agrochemicals Business into a separate entity, issues shares to existing shareholders, and plans listing on major Indian stock exchanges.

Also Read: IRB Infrastructure Shareholders Approve 1:1 Bonus Shares, Record Date Set for April 1

Share price movement of Natco Pharma

On March 25, 2026, Natco Pharma Ltd opened at ₹968.80, up 2.01% from its previous close of ₹949.70. The stock reached a high of ₹987.05 (3.87%) and a low of ₹961.45. By 12:23 PM, it traded at ₹980.50, a 3.24% increase, with a market cap of ₹17,561.72 crore.

Natco Pharma Approves Demerger Plan

Natco Pharma Limited’s Board approved a Scheme of Arrangement to demerge its Agrochemicals business into Natco Crop Health Sciences Limited. The Appointed Date for the demerger is October 1, 2026.

Under the Scheme, one equity share of the Resulting Company will be issued for each equity share held in Natco Pharma. Shareholders will directly hold 80%, and Natco Pharma retains 20% post-demerger.

The Board also approved incorporating Natco Pharma Nigeria Limited with an investment up to USD 100,000. Natco Pharma will liquidate its wholly owned Australian subsidiary, Natco Pharma Australia Pty Ltd.

Stock performance of Natco Pharma for period of 1 week, 6 months, and 1 year

Natco Pharma Ltd delivered a 1-week return of -0.85%, a 6-month return of 15.7%, and a 1-year return of 15.1%.

Also Read: NBCC Up 2% After ₹58.6 Crore Consultancy Order from Odisha University

Shareholding pattern of Natco Pharma

Particulars	Dec 2025	Sep 2025	Jun 2025
Promoter	49.50%	49.50%	49.60%
FII	15%	14%	16%
DII	5.40%	5.90%	5.80%
Public	30.00%	30.60%	29.10%

About Natco Pharma

Natco Pharma Ltd (NSE: NATCOPHARM) is an R&D-driven pharmaceutical company producing and marketing finished dosage formulations, active pharmaceutical ingredients, and contract manufacturing services across niche therapeutic areas.

Stay Ahead with the Latest Stock Market Updates – Click Here

Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.

FAQs